Cagrilintide

Cagrilintide is a synthetic, long-acting analogue of amylin, a hormone co-secreted with insulin by the pancreas. In the research literature it is characterised as an agonist at the amylin and calcitonin receptors, and it carries a fatty-acid modification that extends its half-life. NOX supplies Cagrilintide as a lyophilised research reference material for research use only, and none of this information is medical or human-use guidance.

Cagrilintide is studied through the amylin signalling pathway, which is associated with satiety and gastric-emptying research, whereas GLP-1 peptides are characterised at the incretin receptors. Because the two pathways are complementary, investigators sometimes examine amylin analogues alongside GLP-1 peptides in metabolic-signalling research. This is educational context only; the compound is supplied for research use only.

Cagrilintide is most often referenced in metabolic and energy-balance research, where investigators examine appetite-related signalling, body-weight pathways and receptor activity in laboratory and preclinical models. It is not associated with any medical, therapeutic or human-use application. As with every NOX compound, it is a research reference material intended strictly for research use only.

Lyophilised Cagrilintide is supplied as a sealed, freeze-dried powder and is generally kept frozen and away from light, typically stored at around -20°C for long-term stability, while for shorter periods it can be kept in the fridge at 2–8°C. Keeping the vial sealed limits moisture uptake and helps preserve the dry material. This describes general laboratory handling of lyophilised research compounds and is provided for research use only, not as guidance for any other use.

Bacteriostatic water is commonly used to reconstitute lyophilised research compounds because the small amount of benzyl alcohol it contains helps limit microbial growth in a multi-use vial. It simply dissolves the freeze-dried powder into a liquid so the material can be handled in the laboratory. Reconstitution is performed strictly within a research context; Cagrilintide is supplied by NOX for research use only.

Once reconstituted, Cagrilintide is in solution and generally less stable than the dry powder, so the liquid is typically kept in the fridge at 2–8°C and protected from light. Researchers usually prepare only what a study requires and record the reconstitution date. This reflects general laboratory handling of reconstituted research materials and is offered for research-use-only context, not as guidance for human or veterinary use.

Cagrilintide is supplied as a lyophilised powder in 10 mg. The stated strength is the mass of compound sealed in the vial before reconstitution; the working concentration depends on the volume of solvent a researcher adds during preparation. All presentations are research reference materials supplied for research use only.

Yes. Cagrilintide is supplied by NOX strictly as a research reference material for laboratory and analytical use. It is not a medicinal product, food, cosmetic or veterinary product, and nothing in these answers should be read as guidance for human or animal use. All information here is provided for educational and research context only.